Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFUL.L Regulatory News (FUL)

  • There is currently no data for FUL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off

1 Aug 2022 12:32

Hardman & Co Research Hardman & Co Research: The Fulham Shore (Initiation of coverage): Platform ready for take-off 01-Aug-2022 / 12:32 GMT/BST


Hardman & Co Research on The Fulham Shore (FUL):

Platform ready for take-off

Fulham Shore has two restaurant brands, which are honed and proven in the sector. There is an opportunity to expand the estate to more than double its size in the post-pandemic era. Competition has been reduced and landlords are more realistic. There will still be some stresses due to increasing input costs and consumers’ wallets being squeezed by higher prices, but Fulham Shore’s good-value menus position the company defensively. Trading remains strong. It is currently trading at a discount to its peers and the value of the established platform provides potential further upside.

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/platform-ready-for-take-off/

If you are interested in meeting the company, you can register your interest by clicking on the above link.

To contact us:

Hardman & Co1 Frederick’s Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Jason Streets

+44(0)203 693 7075

 

js@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1410473 01-Aug-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
10th Jan 20087:01 amRNSProposed Board Changes
20th Dec 20075:35 pmRNSResult of AGM
26th Nov 20077:01 amRNSFinal Results
15th Nov 20077:01 amRNSNotice of Results/Trdg Update
6th Nov 20077:01 amRNSOpening of new US office
11th Oct 20077:01 amRNSContract Win
7th Sep 20077:01 amRNSRe Alliance
3rd Sep 20074:13 pmRNSDirector/PDMR Shareholding
20th Aug 20074:09 pmRNSDirector/PDMR Shareholding
17th Aug 20074:37 pmRNSAIM Rule 26
15th Aug 20077:01 amRNSTrading Update
17th May 20077:01 amRNSInterim Results
18th Apr 20074:46 pmRNSDirector/PDMR Shareholding
12th Apr 20071:40 pmRNSEGM Statement
19th Mar 200711:28 amRNSPlacing and Acquisition
21st Feb 20077:00 amRNSCompletion of Earn Out
21st Dec 20069:29 amRNSTotal Voting Rights
18th Dec 200612:52 pmRNSResult of AGM
15th Nov 20062:06 pmRNSDirector/PDMR Shareholding
9th Nov 20067:01 amRNSFinal Results
2nd Aug 20067:00 amRNSDirector/PDMR Shareholding
12th May 20067:01 amRNSEdinburgh Office Opens
9th May 20067:01 amRNSInterim Results
12th Apr 200610:30 amRNSContract with Celtic Pharma
5th Apr 20067:01 amRNSNanoCarrier Partnership
7th Mar 20067:01 amRNSBoard Appointment
9th Feb 20067:01 amRNSAcquisition of Quadramed Ltd
19th Dec 200512:09 pmRNSAGM Statement
14th Nov 200512:18 pmRNSDirector/PDMR Shareholding
9th Nov 20057:00 amRNSPreliminary Results
14th Sep 20057:02 amRNSTrading Update
18th May 20057:01 amRNSSyngenta Biopharma Agreement
18th May 20057:00 amRNSInterim Results
5th May 200512:20 pmRNSNotice of Interim Results
1st Mar 20057:03 amRNSPresent at Networking Evening
25th Jan 20057:00 amRNSPresentation with Addex
6th Jan 20057:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.